3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
24
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Leukemia, Myeloid, Acute
36
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Mantle-Cell
25
Lymphoma, Follicular
24
Multiple Myeloma
22
Lymphoma, B-Cell, Marginal Zone
21
Leukemia
21
Lymphoma, Non-Hodgkin
19
Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
17
Hematologic Neoplasms
16
Waldenstrom Macroglobulinemia
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Myelodysplastic Syndromes
12
Congenital Abnormalities
11
Burkitt Lymphoma
11
Lymphoma, Large-Cell, Immunoblastic
10
Mycosis Fungoides
9
Lymphoma, T-Cell, Cutaneous
9
Lymphoma, Large-Cell, Anaplastic
9
Immunoblastic Lymphadenopathy
9
Sezary Syndrome
8
Recurrence
8
Hodgkin Disease
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Plasma Cell
6
Leukemia, Myelomonocytic, Acute
6
Leukemia, Monocytic, Acute
6
Leukemia, Erythroblastic, Acute
6
Interventions
Peripheral Blood Stem Cell Transplantation
10
Cyclophosphamide
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Cyclosporine
5
Radiotherapy
4
Melphalan
4
Filgrastim
4
Carboplatin
4
Busulfan
4
Tacrolimus
3
Etoposide
3
Epoetin Alfa
3
Darbepoetin alfa
3
sargramostim
2
liposomal amphotericin B
2
Thiotepa
2
Therapeutics
2
Morphine
2
Methylprednisolone
2
Interferon-alpha
2
Fentanyl
2
Early Intervention, Educational
2
Caspofungin
2
Carmustine
2
Antilymphocyte Serum
2
talquetamab
1
pyroxamide
1
nelarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Bortezomib
×
Other hematologic neoplasm
×
Clear all
NCT00006362
2011-08-03
PS-341 in Treating Patients With Advanced Cancer
Mayo Clinic
Phase 1
Completed